1. P813: EFFICACY, TREATMENT ADMINISTRATION SATISFACTION AND SAFETY OF SUBCUTANEOUS RAVULIZUMAB THROUGH 1 YEAR IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA WHO RECEIVED PRIOR INTRAVENOUS ECULIZUMAB. (23rd June 2022) Authors: Yenerel, M. N.; Sicre de Fontbrune, F.; Piatek, C.; Sahin, F.; Füreder, W.; Ogawa, M.; Tomazos, I.; Doll, H.; Ozol-Godfrey, A.; Sierra, J. R.; Szer, J. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 707 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗